151 related articles for article (PubMed ID: 38464822)
1. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy.
Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q
Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822
[No Abstract] [Full Text] [Related]
2. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
Liu B; Zhao L; Yang Q; Zha D; Si X
Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976
[TBL] [Abstract][Full Text] [Related]
4. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for IgA nephropathy.
Liu J; Duan S; Chen P; Cai G; Wang Y; Tang L; Liu S; Zhou J; Wu D; Shen W; Chen X; Wu J
Oncotarget; 2017 Nov; 8(55):94371-94381. PubMed ID: 29212234
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
[TBL] [Abstract][Full Text] [Related]
7. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
8. Established the first clinical prediction model regarding the risk of hyperuricemia in adult IgA nephropathy.
Geng YH; Zhang Z; Zhang JJ; Huang B; Guo ZS; Wang XT; Zhang LQ; Quan SX; Hu RM; Song CD; Duan FY; Liu YF
Int Urol Nephrol; 2023 Jul; 55(7):1787-1797. PubMed ID: 36753014
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R
BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849
[TBL] [Abstract][Full Text] [Related]
10. Development and assessment of a predictive nomogram for the progression of IgA nephropathy.
Liu LL; Zhu LB; Zheng JN; Bi TD; Ma JF; Wang LN; Yao L
Sci Rep; 2018 May; 8(1):7309. PubMed ID: 29743598
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of low-density lipoprotein cholesterol in IgA nephropathy and establishment of nomogram model.
Tian ZY; Li AM; Chu L; Hu J; Xie X; Zhang H
Front Endocrinol (Lausanne); 2023; 14():1037773. PubMed ID: 36843611
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
Guan J; Wang M; Zhao M; Ni W; Zhang M
BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570
[TBL] [Abstract][Full Text] [Related]
13. Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy.
Zhou J; Chen Y; Liu Y; Shi S; Li X; Wang S; Zhang H
BMC Nephrol; 2014 Jan; 15():11. PubMed ID: 24423013
[TBL] [Abstract][Full Text] [Related]
14. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
15. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
[TBL] [Abstract][Full Text] [Related]
16. The Related Factors of Hyperuricemia in IgA Nephropathy.
Yi F; Lan L; Jiang J; Peng L; Jin Y; Zhou X
Iran J Kidney Dis; 2021 Jul; 15(4):256-262. PubMed ID: 34278996
[TBL] [Abstract][Full Text] [Related]
17. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
Wu C; Wang AY; Li G; Wang L
BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
[TBL] [Abstract][Full Text] [Related]
19. Crescentic IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
[TBL] [Abstract][Full Text] [Related]
20. Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.
Li Z; Han Q; Ye H; Li J; Wei X; Zhang R; Huang Q; Xu Y; Liu G; Li B; Yang Q
BMC Nephrol; 2022 Feb; 23(1):78. PubMed ID: 35196994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
